fda approved glutathione Advisory No.2024-1656 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “SWANSON L-Glutathione Dietary Supplement 100 mg (100 Capsules)” FDA Advisory No.2024-1793 || Public

Clinically, BPC-157 is mostly experimental with animal and limited human case evidence

GHK is a short peptide made of three amino acids: glycine, histidine, and lysine

Key Research Areas BPC-157 5mg VEGFR2/ERK1/2 receptor activation and downstream angiogenesis signalling Akt-eNOS nitric oxide pathway and vascular tube formation assays FAK-paxillin pathway fibroblast spreading, migration, and adhesion studies Tendon, ligament, muscle, bone, and skin tissue healing models Anti-inflammatory cytokine modulation TNF-, IL-6 pathway research Gastrointestinal mucosal protection and barrier integrity studies Dose-response research across the full 5mg vial concentration range Key Research Areas TB-500 5mg G-actin sequestration and cytoskeletal reorganisation studies Keratinocyte, endothelial, and stem/progenitor cell migration assays VEGF and actin-binding protein upregulation and angiogenesis initiation Stem and progenitor cell mobilisation and tissue-site differentiation studies Anti-apoptotic signalling and inflammatory cytokine suppression research Cardiac and CNS tissue regeneration pathway studies in pre-clinical models Scar tissue reduction and myofibroblast count modulation research What Do Studies Say About BPC-157 and TB-500

2014 Aug 11;5:181